vs
Side-by-side financial comparison of American Healthcare REIT, Inc. (AHR) and Axon Enterprise (AXON). Click either name above to swap in a different company.
Axon Enterprise is the larger business by last-quarter revenue ($796.7M vs $564.0M, roughly 1.4× American Healthcare REIT, Inc.). American Healthcare REIT, Inc. runs the higher net margin — 1.9% vs 0.3%, a 1.6% gap on every dollar of revenue. On growth, Axon Enterprise posted the faster year-over-year revenue change (38.9% vs 13.5%). Over the past eight quarters, Axon Enterprise's revenue compounded faster (31.5% CAGR vs 11.7%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Axon Enterprise, Inc. is an American company based in Scottsdale, Arizona, that develops weapons and technology products for military, law enforcement, and civilians.
AHR vs AXON — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $564.0M | $796.7M |
| Net Profit | $10.8M | $2.7M |
| Gross Margin | 14.8% | 57.9% |
| Operating Margin | 19.8% | -6.3% |
| Net Margin | 1.9% | 0.3% |
| Revenue YoY | 13.5% | 38.9% |
| Net Profit YoY | 133.9% | -98.0% |
| EPS (diluted) | $0.07 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $564.0M | $796.7M | ||
| Q3 25 | $532.1M | $710.6M | ||
| Q2 25 | $501.3M | $668.5M | ||
| Q1 25 | $497.2M | $603.6M | ||
| Q4 24 | $496.8M | $573.4M | ||
| Q3 24 | $476.8M | $544.3M | ||
| Q2 24 | $458.0M | $504.1M | ||
| Q1 24 | $452.1M | $460.7M |
| Q4 25 | $10.8M | $2.7M | ||
| Q3 25 | $55.9M | $-2.2M | ||
| Q2 25 | $9.9M | $36.1M | ||
| Q1 25 | $-6.8M | $88.0M | ||
| Q4 24 | $-31.8M | $136.0M | ||
| Q3 24 | $-4.1M | $67.0M | ||
| Q2 24 | $2.0M | $40.8M | ||
| Q1 24 | $-3.9M | $133.2M |
| Q4 25 | 14.8% | 57.9% | ||
| Q3 25 | 14.6% | 60.1% | ||
| Q2 25 | 15.0% | 60.4% | ||
| Q1 25 | 13.0% | 60.6% | ||
| Q4 24 | 13.3% | 60.5% | ||
| Q3 24 | 12.5% | 60.8% | ||
| Q2 24 | 12.1% | 60.3% | ||
| Q1 24 | 10.7% | 56.4% |
| Q4 25 | 19.8% | -6.3% | ||
| Q3 25 | 19.9% | -0.3% | ||
| Q2 25 | 20.6% | -0.2% | ||
| Q1 25 | 19.0% | -1.5% | ||
| Q4 24 | 20.0% | -2.6% | ||
| Q3 24 | 19.6% | 4.4% | ||
| Q2 24 | 19.4% | 6.5% | ||
| Q1 24 | 18.2% | 3.5% |
| Q4 25 | 1.9% | 0.3% | ||
| Q3 25 | 10.5% | -0.3% | ||
| Q2 25 | 2.0% | 5.4% | ||
| Q1 25 | -1.4% | 14.6% | ||
| Q4 24 | -6.4% | 23.7% | ||
| Q3 24 | -0.9% | 12.3% | ||
| Q2 24 | 0.4% | 8.1% | ||
| Q1 24 | -0.9% | 28.9% |
| Q4 25 | $0.07 | $0.02 | ||
| Q3 25 | $0.33 | $-0.03 | ||
| Q2 25 | $0.06 | $0.44 | ||
| Q1 25 | $-0.04 | $1.08 | ||
| Q4 24 | $-0.23 | $1.68 | ||
| Q3 24 | $-0.03 | $0.86 | ||
| Q2 24 | $0.01 | $0.53 | ||
| Q1 24 | $-0.04 | $1.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.8M | $1.7B |
| Total DebtLower is stronger | — | $1.8B |
| Stockholders' EquityBook value | $3.3B | $3.2B |
| Total Assets | $5.4B | $7.0B |
| Debt / EquityLower = less leverage | — | 0.56× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.8M | $1.7B | ||
| Q3 25 | $147.4M | $2.4B | ||
| Q2 25 | $133.5M | $2.1B | ||
| Q1 25 | $86.1M | $2.2B | ||
| Q4 24 | $76.7M | $788.1M | ||
| Q3 24 | $67.8M | $1.0B | ||
| Q2 24 | $52.1M | $968.9M | ||
| Q1 24 | $77.0M | $964.1M |
| Q4 25 | — | $1.8B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $680.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $3.3B | $3.2B | ||
| Q3 25 | $2.7B | $3.0B | ||
| Q2 25 | $2.4B | $2.7B | ||
| Q1 25 | $2.3B | $2.6B | ||
| Q4 24 | $2.3B | $2.3B | ||
| Q3 24 | $2.2B | $2.1B | ||
| Q2 24 | $1.9B | $1.9B | ||
| Q1 24 | $2.0B | $1.8B |
| Q4 25 | $5.4B | $7.0B | ||
| Q3 25 | $4.8B | $6.7B | ||
| Q2 25 | $4.5B | $6.2B | ||
| Q1 25 | $4.5B | $6.1B | ||
| Q4 24 | $4.5B | $4.5B | ||
| Q3 24 | $4.7B | $4.0B | ||
| Q2 24 | $4.6B | $3.7B | ||
| Q1 24 | $4.7B | $3.6B |
| Q4 25 | — | 0.56× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 0.79× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $55.2M | $217.2M |
| Free Cash FlowOCF − Capex | — | $155.4M |
| FCF MarginFCF / Revenue | — | 19.5% |
| Capex IntensityCapex / Revenue | — | 7.8% |
| Cash ConversionOCF / Net Profit | 5.12× | 79.14× |
| TTM Free Cash FlowTrailing 4 quarters | — | $75.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.2M | $217.2M | ||
| Q3 25 | $107.2M | $60.0M | ||
| Q2 25 | $71.5M | $-91.7M | ||
| Q1 25 | $60.6M | $25.8M | ||
| Q4 24 | $59.5M | $250.2M | ||
| Q3 24 | $63.1M | $91.3M | ||
| Q2 24 | $59.4M | $82.8M | ||
| Q1 24 | $-6.0M | $-15.9M |
| Q4 25 | — | $155.4M | ||
| Q3 25 | — | $33.4M | ||
| Q2 25 | — | $-114.7M | ||
| Q1 25 | — | $932.0K | ||
| Q4 24 | — | $225.4M | ||
| Q3 24 | — | $64.8M | ||
| Q2 24 | — | $71.4M | ||
| Q1 24 | — | $-32.1M |
| Q4 25 | — | 19.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | -17.2% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 39.3% | ||
| Q3 24 | — | 11.9% | ||
| Q2 24 | — | 14.2% | ||
| Q1 24 | — | -7.0% |
| Q4 25 | — | 7.8% | ||
| Q3 25 | — | 3.7% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 4.1% | ||
| Q4 24 | — | 4.3% | ||
| Q3 24 | — | 4.9% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 3.5% |
| Q4 25 | 5.12× | 79.14× | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 7.21× | -2.54× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | — | 1.36× | ||
| Q2 24 | 30.02× | 2.03× | ||
| Q1 24 | — | -0.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHR
| Integrated Senior Health Campuses | $467.0M | 83% |
| SHOP | $97.0M | 17% |
AXON
| Software And Sensors Segment | $342.5M | 43% |
| TASER Devices Professional | $264.2M | 33% |
| Personal Sensors | $109.1M | 14% |
| Platform Solutions | $80.9M | 10% |
